Mopec, Inc. a full line manufacturer of pathology and mortuary equipment in Oak Park, Michigan was acquired by Blackford Capital. Charter provided investment banking advisory services to Blackford Capital.
Charter principals were lead advisors of a Series B fundraising effort for Grand River Aseptic Manufacturing (GRAM). GRAM manufactures small-run, high-value clinical trial drugs that most large pharmaceutical companies cannot produce profitably.
Charter participated in a Series A capital investment. Playing an active co-lead investor role with Hopen Life Sciences and Hope River Ventures, Charter was instrumental in the completion of the funding to facilitate the commercial launch of the Intervention Insights business.
Charter Capital Fund I has made a private investment in Alliant Healthcare Products in Richland, Michigan. Alliant is a veteran owned manufacturer and distributor of medical devices and equipment. Charter principals formed Charter Capital I along with other investors to invest in Alliant.
Charter Capital Fund II, LLC has made a private investment in Metabolic Solutions Development Company in Kalamazoo, Michigan. MSD is a developer of innovative therapeutics to treat diabetes and related symptoms of metabolic syndrome. Charter principals formed Charter Capital Fund II along with other investors to invest in MSD.
A pharmaceutical processing company in Holland, Michigan, was acquired by a private investor. Charter served as exclusive investment banking advisors to Welch Laboratories Inc.
A medical device manufacturer in Grand Rapids, Michigan, received a secured investment from Brauer Capital LLC, an investment firm based in Atlanta, Georgia. The Charter Group served as exclusive M&A advisor to the shareholders of Vital Concepts Inc.